Table 2.
Chemotherapeutic variables
| Number of patients (%) | |
|---|---|
| Total patients | 29 |
| Number of cycles | 6 (3–31) |
| Type of first-line chemotherapy | |
| Capecitabine | 11 |
| Capecitabine + oxaliplatin | 6 |
| Irinotecan | 4 |
| Fluorouracil + oxaliplatin + leucovorin | 3 |
| Capecitabine + oxaliplatin + bevacizumab | 2 |
| Cetuximab | 1 |
| Capecitabine + bevacizumab | 1 |
| Fluorouracil + leucovorin | 1 |
| Switch to second-line chemotherapy | |
| Yes | 12 |
| No | 17 |